Brian Meshkin from Lake Forest, CA, age 48

Resumes

Founder And President

view source

Location:

15 Crespi Cir, Ladera Ranch, CA 92694

Industry:

Biotechnology

Work:

Howard County Public Schools since Dec 2010
Vice Chairman, Board of Education of Howard County
Proove Biosciences, Inc. - Los Angeles, CA since Dec 2009
Founder and President
Meshkin Ventures Jan 2008 - Jun 2011
Independent Consultant and Investor
Howard Community College Aug 2009 - Aug 2010
Adjunct Professor of Entrepreneurship
Salugen, Inc. - San Diego, California Apr 2005 - Jul 2009
President and CEO

Education:

University of Maryland College Park 1995 - 1997
Bachelors, Government & Politics and General Business Glenelg High School 1990 - 1994

Skills:

Entrepreneurship
Strategic Planning
Leadership
Strategy
Cross Functional Team Leadership
Marketing Strategy
Marketing
Management
Biotechnology
Community Outreach
Healthcare
Sales
Consulting
Leadership Development
Team Building
Pharmaceutical Industry
Product Management
Fundraising
Social Entrepreneurship
Executive Management
Start Ups
Medical Devices
Corporate Development
Personalized Medicine
Strategic Thinking
Management Consulting
Instructional Technology
Selling
Commercialization
Educational Leadership
Cancer
Medical Diagnostics
Innovation
Strategic Partnerships
Lifesciences
Business Planning
Pharmacogenetics
Molecular Genetics
Angel Investing
Corporate Venture Capital
Senior Executive Leadership
Technological Innovation
Business Innovation
Organizational Development
Small Business
Infectious Diseases
Competitive Analysis
Education Policy
Ebusiness Suite
Digital Education

Interests:

Experiencing Life With My Family
Coaching and Playing Sports
Tweetdeck
Volunteering For Good Causes
Politics
Seeing the World Through My Kids' Eyes
Web Marketing
Problem Solving
Hootsuite
American Red Cross (National Society)
The Washington Post
Reforming Public Policy
Gifts
Beowulf
Open Government
Glenn Beck

Languages:

English
French

Brian Meshkin

view source

Us Patents

System And Method For Processing Genotype Information Relating To Opioid Response
view source
US Patent:

20190080048, Mar 14, 2019
Filed:

Apr 28, 2016
Appl. No.:

15/570312
Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US
International Classification:

G16H 50/20
C12Q 1/6858
C12Q 1/6883
C12Q 1/6827
Abstract:

There are systems and methods for preparing or using prognostic information about opioid response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining an opioid response associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

System And Method For Processing Genotype Information Relating To Drug Metabolism
view source
US Patent:

20190055603, Feb 21, 2019
Filed:

Apr 28, 2016
Appl. No.:

15/570311
Inventors:

- Annapolis MD, US
Brian MESHKIN - Ladera Ranch CA, US
International Classification:

C12Q 1/6883
G16H 50/20
C12Q 1/02
G06F 19/10
G16H 10/60
Abstract:

There are systems and methods for preparing or using prognostic information about drug metabolism response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more alleles or haplotypes in the one or more genes of the subject genotype by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more alleles or haplotypes.

System And Method For Processing Genotype Information Relating To Medically-Assisted Treatment Regarding Withdrawal Or Pain
view source
US Patent:

20190018923, Jan 17, 2019
Filed:

Apr 28, 2016
Appl. No.:

15/570317
Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US
International Classification:

G06F 19/18
G06F 19/22
G16H 50/30
G16H 10/60
Abstract:

There are systems and methods for preparing or using prognostic information about opioid maintenance response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining an opioid maintenance response associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

System And Method For Processing Genotype Information Relating To Nsaid Risk
view source
US Patent:

20180322960, Nov 8, 2018
Filed:

Apr 28, 2016
Appl. No.:

15/570315
Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US
International Classification:

G16H 70/40
G06F 19/22
G06F 19/28
G06F 19/18
Abstract:

There are systems and methods for preparing or using prognostic information about NSAID mediated side effect risks. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining a NSAID mediated side effect risk associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

System And Method For Processing Genotype Information Relating To Non-Opioid Response
view source
US Patent:

20180247013, Aug 30, 2018
Filed:

Apr 28, 2016
Appl. No.:

15/570314
Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US
International Classification:

G06F 19/22
C12Q 1/6876
G06F 19/18
Abstract:

There are systems and methods for preparing or using prognostic information about non-opioid response. The information may include determining patient information, including DNA information, associated with a human subject; determining from the DNA information whether a subject genotype of the human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype, wherein each SNP diploid polymorphism of the one or more SNP diploid polymorphisms includes a combination of two SNP alleles associated with one SNP location; and determining a non-opioid response associated with the human subject based, at least in part, on the presence or absence of the one or more SNP diploid polymorphisms in the subject genotype.

System And Method For Processing Genotype Information Relating To Opioid Risk
view source
US Patent:

20180137235, May 17, 2018
Filed:

Apr 28, 2016
Appl. No.:

15/570306
Inventors:

- Irvine CA, US
Brian MESHKIN - Ladera Ranch CA, US
International Classification:

G06F 19/18
G06F 19/22
G16H 50/30
G16H 10/60
Abstract:

There are methods, apparati and computer readable mediums associated with determining patient information, including DNA information, and determining from the DNA information whether a subject genotype of a human subject includes one or more SNP diploid polymorphisms by detecting, utilizing a detection technology and the DNA information, a presence or absence of the one or more SNP diploid polymorphisms in the subject genotype. The SNP diploid polymorphisms are selected from a SNP diploid group and utilized in determining an opioid dependency risk associated with the human subject.

System And Method For Performing Medical Research
view source
US Patent:

20150161358, Jun 11, 2015
Filed:

Dec 6, 2013
Appl. No.:

14/099368
Inventors:

Brian Meshkin - Irvine CA, US
Brian Meshkin - Fulton MD, US
International Classification:

G06F 19/00
Abstract:

There is a system and a method for performing medical research. The method includes receiving a registration record. The registration record is for documenting a participant's involvement in a clinical trial. The method may also include receiving an evaluation record for documenting biological information associated with the participant in the clinical trial. The method may also include generating a payment record. The payment record may include a payment value associated with the evaluation record. The registration record may include a service authorization. The service authorization may be for a service the participant receives for collecting the biological information.